series-b
Stage
2
Investors
About
HVR Cardio develops a transcatheter mitral valve repair system called CathHELIX, aiming to treat mitral regurgitation through a minimally invasive approach without open-heart surgery.
Explore HVR Cardio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.